System und Verfahren zur Anwendung einer Gezielten und Optimalen Transkranialen Magnetischen Stimulationsbehandlung

Details

Veröffentlichungs-Nr.

EP4796167

Anmeldetag

25. Februar 2025

Veröffentlichung

26. August 2026

Rechtsraum

EP

Abstract

A system and method for identifying the maximum anticorrelation point between dorsolateral prefrontal cortex (DLPFC) and Subgenual Anterior Cingulate Cortex (sgACC), identifying the motor hotspot, calculating the motor threshold (MT), predicting Transcranial Magnetic Stimulation (TMS) intensity, and ensuring real-time precision in TMS treatment using multimodal functional Magnetic Resonance Imaging (fMRI) and Electroencephalography (EEG) data, Electromyography (EMG) data, neuronavigator devices, and a robotized support. The system leverages AI architectures to process and integrate fMRI and EEG data, enabling precise localization of the target for TMS treatment of depression and addictions, and personalized determination of TMS intensity, and TMS sessions scheduling and duration parameters. The integration with neuronavigator and robotized hardware systems ensures real-time adjustments to maintain accurate stimulation targeting (location and tilt) despite patient head movements or coil misalignments. The invention improves the precision, safety, and efficacy of TMS targeting, leading to better outcomes for patients with depression and addictions.

Anmelder

Firma

Connectoma Neurotech SL

Land

🇪🇸 Spanien